Elevance Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Shareholders held by Elevance Health, Inc. on May 15, 2024. The filing details the voting outcomes for director elections, executive compensation, auditor ratification, and a shareholder proposal.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Election of Directors: All three nominees (Lewis Hay, III; Antonio F. Neri; Ramiro G. Peru) were elected to three-year terms expiring in 2027. Notably, Ramiro G. Peru received the highest number of "Against" votes (12,625,588) among the nominees.
- Executive Compensation: The advisory vote on executive compensation was approved, though it received 15,863,613 "Against" votes.
- Auditor Ratification: The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2024 was ratified.
- Shareholder Proposal: A proposal requesting annual political activity reporting from third parties prior to donations was not approved, receiving 184,179,837 "Against" votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the specific reasons for the elevated "Against" votes on Director Ramiro G. Peru and the executive compensation advisory vote.
- Review the full proxy statement for details on the rejected shareholder proposal regarding political activity reporting.
- Confirm the total number of shares outstanding to calculate the percentage of votes cast for each proposal.